Molecular Interplay between Dormant Bone Marrow-Resident Cells (BMRCs) and CTCs in Breast Cancer.

Boral, Debasish; Liu, Haowen N; Kenney, S Ray; Marchetti, Dario

Boral, Debasish; Liu, Haowen N; Kenney, S Ray; Marchetti, Dario.

Afiliación

Boral D; Center for Immunotherapy Research, Houston Methodist Research Institute, Houston, TX 77030, USA.
Liu HN; Biochemistry lab, Complete Genomics Inc., San Jose, CA 95134, USA.
Kenney SR; Division of Molecular Medicine, Department of Internal Medicine, The University of New Mexico, Health Sciences Center, Albuquerque, NM 87131, USA.
Marchetti D; Division of Molecular Medicine, Department of Internal Medicine, The University of New Mexico, Health Sciences Center, Albuquerque, NM 87131, USA.

Cancers (Basel) ; 12(6)2020 Jun 19.

Article en En | MEDLINE | ID: mdl-32575420

Palabras clave

Bone Marrow-Resident Breast Cancer Cells (BMRCs); CTC-associated dormancy; CTC-derived xenograft (CDX); Circulating Tumor Cells (CTCs); RICTOR; bone marrow (BM); mTOR pathway; mTORC1/mTORC2 signaling

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: Cancers (Basel) Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google